Virus-Enabled Biosensor for Human Serum Albumin.

Area of Science:

• Biosensor technology
• Nanomaterials
• Electrochemical detection

Background:

• Label-free detection methods are crucial for efficient biomolecule analysis.
• Existing biosensors often require complex sample preparation or labeling.
• Developing sensitive and reproducible biosensors for protein detection remains a key challenge.

Purpose of the Study:

• To demonstrate a label-free electrochemical biosensor for human serum albumin (HSA) detection.
• To utilize a composite of M13 virus particles and poly(3,4-ethylenedioxy thiophene) (PEDOT) for selective HSA binding.
• To investigate the sensor's performance characteristics, including sensitivity, response time, and reproducibility.

Main Methods:

• Fabrication of a two-electrode electrochemical biosensor with electrodes coated in a virus-PEDOT composite.
• Engineering M13 virus particles for selective binding of HSA.
• Measuring the electrical impedance (Zre) changes upon HSA exposure.
• Utilizing a microfluidic cell for small sample volume analysis (50 μL).

Main Results:

• The virus-PEDOT biosensor demonstrated label-free detection of HSA in aqueous buffer.
• A rapid increase in Zre was observed within 5 seconds of HSA exposure, stabilizing within 15 minutes.
• The sensor detected HSA concentrations ranging from 100 nM to 5 μM with high reproducibility (COV 2-8%).
• Successful detection of HSA was achieved in synthetic urine samples.

Conclusions:

• The developed M13 virus-PEDOT electrochemical biosensor is a promising tool for sensitive and rapid label-free HSA detection.
• The sensor's ability to function in complex matrices like synthetic urine highlights its potential for diagnostic applications.
• This monolithic, two-electrode system offers a simple yet effective approach for biosensing.